These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evaluation of a focal lesion in the liver. answer to the clinical challenges and images in GI question: image 3: Focal fatty infiltration. Tharayil V; Roberts LR Gastroenterology; 2010 Aug; 139(2):e10-1. PubMed ID: 20600054 [No Abstract] [Full Text] [Related]
7. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. Omer Z; Cetinkalp S; Akyildiz M; Yilmaz F; Batur Y; Yilmaz C; Akarca U Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):18-23. PubMed ID: 19667999 [TBL] [Abstract][Full Text] [Related]
9. Review of treatment options for nonalcoholic fatty liver disease. Corrado RL; Torres DM; Harrison SA Med Clin North Am; 2014 Jan; 98(1):55-72. PubMed ID: 24266914 [TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease: a challenge for pediatricians. Widhalm K; Ghods E Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401 [TBL] [Abstract][Full Text] [Related]
11. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. Farrell GC; Chitturi S; Lau GK; Sollano JD; J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629 [No Abstract] [Full Text] [Related]
12. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic. Ismail MH Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139 [TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease. Bayard M; Holt J; Boroughs E Am Fam Physician; 2006 Jun; 73(11):1961-8. PubMed ID: 16770927 [TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitis: a review of the literature and updates in management. Pasumarthy L; Srour J South Med J; 2010 Jun; 103(6):547-50. PubMed ID: 20710138 [TBL] [Abstract][Full Text] [Related]